A team of scientists has developed a new version of a common antibiotic that may be far more powerful against a dangerous stomach bacterium linked to cancer. The research, carried out at the Technical ...
Biomerica has received its first commercial order for Hp Detect(TM), from one of the largest clinical laboratory chains operating across Europe. -- Strategic Account: This new lab's scale and ...
Infectious diseases are a major cause of death worldwide, and diagnosing bacterial infections remains a challenge in medicine ...
It could enable doctors to diagnose infections such as pneumonia much quicker - without the need for invasive blood tests.
Researchers at the Technical University of Munich have developed a new drug candidate that significantly enhances the effectiveness of the antibiotic metronidazole against Helicobacter pylori, a ...
First Commercial Order by Large Lab Chain: Biomerica has received its first commercial order for Hp Detect™, from one of the largest clinical laboratory chains operating across Europe.
A significant step toward the potential prevention of stomach cancer: Researchers at the Technical University of Munich (TUM) have increased the effectiveness of a standard antibiotic by a factor of ...
Researchers at the Technical University of Munich (TUM) have increased the effectiveness of a standard antibiotic by a factor ...
The Irvine, California-based company will now market its test to clinical labs throughout the UK for patient testing.
MHRA registration authorizes hp+detect™ for commercial sale in Great BritainActive Commercialization: Biomerica is in active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results